169 related articles for article (PubMed ID: 23413249)
1. The effect of pulse sequence parameters and contrast agent dose on percentage signal recovery in DSC-MRI: implications for clinical applications.
Boxerman JL; Paulson ES; Prah MA; Schmainda KM
AJNR Am J Neuroradiol; 2013 Jul; 34(7):1364-9. PubMed ID: 23413249
[TBL] [Abstract][Full Text] [Related]
2. Effects of MRI Protocol Parameters, Preload Injection Dose, Fractionation Strategies, and Leakage Correction Algorithms on the Fidelity of Dynamic-Susceptibility Contrast MRI Estimates of Relative Cerebral Blood Volume in Gliomas.
Leu K; Boxerman JL; Ellingson BM
AJNR Am J Neuroradiol; 2017 Mar; 38(3):478-484. PubMed ID: 28034995
[TBL] [Abstract][Full Text] [Related]
3. Validation of combined use of DWI and percentage signal recovery-optimized protocol of DSC-MRI in differentiation of high-grade glioma, metastasis, and lymphoma.
Cindil E; Sendur HN; Cerit MN; Dag N; Erdogan N; Celebi FE; Oner Y; Tali T
Neuroradiology; 2021 Mar; 63(3):331-342. PubMed ID: 32821962
[TBL] [Abstract][Full Text] [Related]
4. The effect of paramagnetic contrast media on T1 relaxation times in brain tumors.
Aronen HJ; Niemi P; Kwong KK; Pardo FS; Davis TL
Acta Radiol; 1998 Sep; 39(5):474-81. PubMed ID: 9755693
[TBL] [Abstract][Full Text] [Related]
5. Utility of Percentage Signal Recovery and Baseline Signal in DSC-MRI Optimized for Relative CBV Measurement for Differentiating Glioblastoma, Lymphoma, Metastasis, and Meningioma.
Lee MD; Baird GL; Bell LC; Quarles CC; Boxerman JL
AJNR Am J Neuroradiol; 2019 Sep; 40(9):1445-1450. PubMed ID: 31371360
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of gadodiamide versus gadobutrol for contrast-enhanced MR imaging in a rat brain glioma model at 1.5 and 3 T.
Morelli JN; Runge VM; Vu L; Loynachan AT; Attenberger UI
Invest Radiol; 2010 Dec; 45(12):810-8. PubMed ID: 20856127
[TBL] [Abstract][Full Text] [Related]
7. Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors.
Paulson ES; Schmainda KM
Radiology; 2008 Nov; 249(2):601-13. PubMed ID: 18780827
[TBL] [Abstract][Full Text] [Related]
8. Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease.
Seeger A; Braun C; Skardelly M; Paulsen F; Schittenhelm J; Ernemann U; Bisdas S
Acad Radiol; 2013 Dec; 20(12):1557-65. PubMed ID: 24200483
[TBL] [Abstract][Full Text] [Related]
9. Can the apparent diffusion coefficient be used as a noninvasive parameter to distinguish tumor tissue from peritumoral tissue in cerebral gliomas?
Pauleit D; Langen KJ; Floeth F; Hautzel H; Riemenschneider MJ; Reifenberger G; Shah NJ; Müller HW
J Magn Reson Imaging; 2004 Nov; 20(5):758-64. PubMed ID: 15503327
[TBL] [Abstract][Full Text] [Related]
10. Abnormalities in the recirculation phase of contrast agent bolus passage in cerebral gliomas: comparison with relative blood volume and tumor grade.
Jackson A; Kassner A; Annesley-Williams D; Reid H; Zhu XP; Li KL
AJNR Am J Neuroradiol; 2002 Jan; 23(1):7-14. PubMed ID: 11827869
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Brain Tumor Contrast-enhancement on T1-CUBE and 3D-SPGR Images.
Majigsuren M; Abe T; Kageji T; Matsuzaki K; Takeuchi M; Iwamoto S; Otomi Y; Uyama N; Nagahiro S; Harada M
Magn Reson Med Sci; 2016; 15(1):34-40. PubMed ID: 26104076
[TBL] [Abstract][Full Text] [Related]
12. Contrast enhancement of brain tumors at different MR field strengths: comparison of 0.5 T and 2.0 T.
Chang KH; Ra DG; Han MH; Cha SH; Kim HD; Han MC
AJNR Am J Neuroradiol; 1994 Sep; 15(8):1413-9; discussion 1420-3. PubMed ID: 7985558
[TBL] [Abstract][Full Text] [Related]
13. Characterizing the Influence of Preload Dosing on Percent Signal Recovery (PSR) and Cerebral Blood Volume (CBV) Measurements in a Patient Population With High-Grade Glioma Using Dynamic Susceptibility Contrast MRI.
Bell LC; Hu LS; Stokes AM; McGee SC; Baxter LC; Quarles CC
Tomography; 2017 Jun; 3(2):89-95. PubMed ID: 28825039
[TBL] [Abstract][Full Text] [Related]
14. Consistency of normalized cerebral blood volume values in glioblastoma using different leakage correction algorithms on dynamic susceptibility contrast magnetic resonance imaging data without and with preload.
Hedderich D; Kluge A; Pyka T; Zimmer C; Kirschke JS; Wiestler B; Preibisch C
J Neuroradiol; 2019 Feb; 46(1):44-51. PubMed ID: 29753641
[TBL] [Abstract][Full Text] [Related]
15. Role of perfusion-weighted imaging at 3 Tesla in the assessment of malignancy of cerebral gliomas.
Di Costanzo A; Pollice S; Trojsi F; Giannatempo GM; Popolizio T; Canalis L; Armillotta M; Maggialetti A; Carriero A; Tedeschi G; Scarabino T
Radiol Med; 2008 Feb; 113(1):134-43. PubMed ID: 18338133
[TBL] [Abstract][Full Text] [Related]
16. Percentage signal recovery derived from MR dynamic susceptibility contrast imaging is useful to differentiate common enhancing malignant lesions of the brain.
Mangla R; Kolar B; Zhu T; Zhong J; Almast J; Ekholm S
AJNR Am J Neuroradiol; 2011; 32(6):1004-10. PubMed ID: 21511863
[TBL] [Abstract][Full Text] [Related]
17. Clinical Significance of Discrepancy between Arterial Spin Labeling Images and Contrast-enhanced Images in the Diagnosis of Brain Tumors.
Abe T; Mizobuchi Y; Sako W; Irahara S; Otomi Y; Obama Y; Nakajima K; Khashbat D; Majigsuren M; Kageji T; Nagahiro S; Harada M
Magn Reson Med Sci; 2015; 14(4):313-9. PubMed ID: 26104074
[TBL] [Abstract][Full Text] [Related]
18. Optimization of DSC MRI Echo Times for CBV Measurements Using Error Analysis in a Pilot Study of High-Grade Gliomas.
Bell LC; Does MD; Stokes AM; Baxter LC; Schmainda KM; Dueck AC; Quarles CC
AJNR Am J Neuroradiol; 2017 Sep; 38(9):1710-1715. PubMed ID: 28684456
[TBL] [Abstract][Full Text] [Related]
19. High-field, high-resolution, susceptibility-weighted magnetic resonance imaging: improved image quality by addition of contrast agent and higher field strength in patients with brain tumors.
Pinker K; Noebauer-Huhmann IM; Stavrou I; Hoeftberger R; Szomolanyi P; Weber M; Stadlbauer A; Grabner G; Knosp E; Trattnig S
Neuroradiology; 2008 Jan; 50(1):9-16. PubMed ID: 17876570
[TBL] [Abstract][Full Text] [Related]
20. Moving Toward a Consensus DSC-MRI Protocol: Validation of a Low-Flip Angle Single-Dose Option as a Reference Standard for Brain Tumors.
Schmainda KM; Prah MA; Hu LS; Quarles CC; Semmineh N; Rand SD; Connelly JM; Anderies B; Zhou Y; Liu Y; Logan B; Stokes A; Baird G; Boxerman JL
AJNR Am J Neuroradiol; 2019 Apr; 40(4):626-633. PubMed ID: 30923088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
